RNAimmune is a biopharmaceutical company specializing in the discovery and development of mRNA-based therapeutics and vaccines. RNAimmune is backed by investors that include Terra Magnum Capital Partners (“TMCP”) and is headquartered in Gaithersburg.
INDUSTRY:
Biotechnology, Life Science
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
